Congenital pulmonary lesions in children may present diversely in different age groups. Annual incidence of congenital thoracic malformation is 4.4/10,000 (
1). A subdivision of these is categorized as cystic lesions (
2). There have always been controversies about their origin, nomenclature, pathology, and even therapeutic approaches (
1,
2). Congenital pulmonary airway malformation (CPAM), previously called congenital cystic adenomatoid malformation (CCAM), with the incidence of 1/11,000 to 1/35,000, is subdivided into five types (
1-
3). It is known that this lesion has the potential for prenatal regression and that it may retain its primary size or grow and bring about pulmonary hypoplasia and hydrops (
2,
3). Early diagnosis by gestational routine ultrasonography, with positive predictive value and the sensitivity of ranges between 45% - 57% and 70% - 81%, respectively, is of great value in many ways (
4). First, if indicated, by fetal interventions, growth and normal development of pulmonary tissue will be guaranteed. Second, the consequences of a maladapted newborn, such as respiratory distress, long hospitalizations, frequent infectious complications, and malignancy transformation will be prevented. Third, by serial ultrasonographic monitoring, the natural course of the lesions (e.g., regressing, progressing, reaching a plateau, or even disappearing) can be followed.
Bronchopulmonary Sequestrations (BPSs), as non-functional pulmonary tissues, comprise up to 14% to 30% of congenital lung lesions (
1-
3). They are classified as extra lobar sequestration (ELS) and intra lobar sequestration (ILS). ILS is often located in the posterior basal segment of the left lower lobe. ELS, in almost 50% of cases, has associated malformations, such as congenital diaphragmatic hernia (
1-
3). ELS is found more often in the left lower lobe and is more prevalent in males (
3). These two groups differ regarding venous drainage; ILS is drained into the pulmonary, but ELS is drained into the systemic (e.g., azygos or portal vein) venous system (
1,
3). Detection of vascular supply is important for surgical excisional planning. There may be found a prenatal history of polyhydramnios (
1-
3). Moreover, some of these lesions seem to disappear postnatally. These lesions have a more favorable outcome than CCAMs (
2,
3). The combination of an aberrant systemic blood supply and an echogenic lung mass in prenatal ultrasonography is pathognomonically in favor of sequestration (
2).
Congenital Lobar Emphysema (CLE) is mostly seen in males and affects the left upper lobe (42%), right middle lobe (35%), right upper lobe (21%), and lower lobes (2%), in sequence of prevalence (
2,
3). Spontaneous regression in the third trimester is not unusual in CLEs. Asymptomatic lesions, or ones with minimal symptoms, may be followed conservatively, contrary to CCAMs and PSs, which hold the risk of later infection and malignancy transformation. CLE is rarely documented in prenatal ultrasonographies (
2,
3).
Bronchogenic cysts (BCs) are found in the mediastinum in up to two-thirds of cases, with the remainder found within the lung parenchyma (
1-
3). Most cases present postnatally, usually with pulmonary infection. Malignant transformation has not been reported in relation to these lesions. Some clinicians choose to manage them conservatively, while others prefer surgery, based on the patient’s symptoms or the mass’s complications (
1-
3).